{"data":{"id":"us-nh/rsa-328-d-6-a","jurisdiction":"us-nh","citation":"RSA 328-D:6-a","heading":"Off-label Use of Prescription Drugs; When Permitted.","body":"The state of New Hampshire confirms its strong support for shared decision making between healthcare professionals and their patients. A licensee may lawfully prescribe an FDA approved drug product for an off-label indication and be held to the same standard of care as when prescribing for on-label indication when:\nI. Off-label use of the drug product for this indication has longstanding common use;\nII. There is medical evidence to support this use and no known evidence contraindicating such use, including but not limited to peer reviewed studies and practice guidelines from relevant medical societies; or\nIII. The licensee has provided and the patient, or if the patient is a minor, the patient's parent or guardian, has signed an informed consent form that includes the known potential benefits, known potential risks, alternative treatment options, expected prognosis without treatment, and a disclosure that a prescription is for an off-label indication. The signed informed consent form shall remain part of the patient's medical record.","path":["Title XXX: OCCUPATIONS AND PROFESSIONS","Chapter 328-D: PHYSICIAN ASSOCIATES"],"source_url":"https://gc.nh.gov/rsa/html/XXX/328-D/328-D-6-a.htm","current_through":"2025 regular legislative session, or December 2025","vintage":"","retrieved_at":"2026-09-05T15:08:03Z","sha256":"9ebdf60929d27ce7c09a12751462d5d8263da1124efa9a0a4dd63f3b888a103d","source_id":"us-nh","stale":false,"prev":"us-nh/rsa-328-d-6","next":"us-nh/rsa-328-d-7"},"notice":"GroundRules: Original legal text. Not legal advice."}